INFY Stock Analysis: Infosys | NYSE
Information Technology Services | NYSE, USA | Market Cap: 50.630m USD | 12M Return: -21.5% | US4567881085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 259M
EPS Trend: 88.1%
Qual. Beats: -2
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Infosys Limited is a global provider of consulting, technology, outsourcing, and digital services, headquartered in Bengaluru, India. The company offers a broad portfolio spanning AI and generative AI services (including its Infosys Topaz suite), blockchain, IoT, cybersecurity, cloud and enterprise modernization, digital marketing, and industry-specific platforms such as Finacle (banking) and Cobalt (cloud). It serves virtually every major industry vertical, from financial services and healthcare to manufacturing, energy, and the public sector.
As one of Indias flagship IT services exporters, Infosys operates within a labor-arbitrage business model that monetizes a large, India-based talent pool delivering work for clients in North America, Europe, and other markets. The IT consulting and services sector is highly competitive, with pricing tied largely to billable hours and offshore-onsite mix, making workforce utilization and digital capabilities like AI key levers for margin expansion. The company was incorporated in 1981 and listed on the NYSE in 1999.
- Infosys Topaz AI deal pipeline accelerates with enterprise clients
- US visa policy tightening pressures Indian IT margins and onsite costs
- Financial services vertical spending rebounds boosting BFSI segment revenue
- Large deal TCV growth signals strong demand visibility
- Currency headwinds from rupee volatility impact reported revenue
- Generative AI pricing pressures compress traditional outsourcing billing rates
| Net Income: 3.30b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -1.63 > 1.0 |
| NWC/Revenue: 26.40% < 20% (prev 33.99%; Δ -7.59% < -1%) |
| CFO/TA 0.23 > 3% & CFO 3.98b > Net Income 3.30b |
| Net Debt (-3.09b) to EBITDA (5.06b): -0.61 < 3 |
| Current Ratio: 1.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.05b) vs 12m ago -4.78% < -2% |
| Gross Margin: 30.41% > 18% (prev 30.52%; Δ -0.11% > 0.5%) |
| Asset Turnover: 116.0% > 50% (prev 108.9%; Δ 7.06% > 0%) |
| Interest Coverage Ratio: 94.09 > 6 (EBIT TTM 4.50b / Interest Expense TTM 47.8m) |
| A: 0.32 (Total Current Assets 11.0b - Total Current Liabilities 5.59b) / Total Assets 17.1b |
| B: 0.53 (Retained Earnings 8.96b / Total Assets 17.1b) |
| C: 0.26 (EBIT TTM 4.50b / Avg Total Assets 17.6b) |
| D: 1.55 (Book Value of Equity 10.3b / Total Liabilities 6.67b) |
| Altman-Z'' = 7.13 = AAA |
| DSRI: 0.97 (Receivables 6.05b/6.00b, Revenue 20.4b/19.7b) |
| GMI: 1.00 (GM 30.52% / 30.41%) |
| AQI: 1.07 (AQ_t 0.24 / AQ_t-1 0.22) |
| SGI: 1.04 (Revenue 20.4b / 19.7b) |
| TATA: -0.04 (NI 3.30b - CFO 3.98b) / TA 17.1b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of November 11, 2026, the stock is trading at USD 12.59 with a total of 12,070,127 shares traded. Over the past week, the price has changed by +5.53%, over one month by +16.25%, over three months by +2.49% and over the past year by -21.54%.
Current recommended Stop Loss: 11.90 (which is 5.5% or 1.6 ATR below the current price).
Infosys has received a consensus analysts rating of 3.29. Therefore, it is recommended to hold INFY.
- StrongBuy: 1
- Buy: 2
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.1 | -4.1% |
P/E Trailing = 15.4321
P/E Forward = 15.2905
P/S = 2.4859
P/B = 4.8998
P/EG = 2.1527
Revenue TTM = 20.4b USD
EBIT TTM = 4.50b USD
EBITDA TTM = 5.06b USD
Long Term Debt = 515.7m USD (estimated: total debt 889.6m - short term 373.9m)
Short Term Debt = 373.9m USD (from shortTermDebt, last quarter)
Debt = 889.6m USD (from shortLongTermDebtTotal, last quarter) (leases 890.0m already included)
Net Debt = -3.09b USD (calculated: Debt 889.6m - CCE 3.98b)
Enterprise Value = 47.5b USD (50.6b + Debt 889.6m - CCE 3.98b)
Interest Coverage Ratio = 94.09 (Ebit TTM 4.50b / Interest Expense TTM 47.8m)
EV/FCF = 12.97x (Enterprise Value 47.5b / FCF TTM 3.67b)
FCF Yield = 7.71% (FCF TTM 3.67b / Enterprise Value 47.5b)
FCF Margin = 17.99% (FCF TTM 3.67b / Revenue TTM 20.4b)
Net Margin = 16.21% (Net Income TTM 3.30b / Revenue TTM 20.4b)
Gross Margin = 30.41% ((Revenue TTM 20.4b - Cost of Revenue TTM 14.2b) / Revenue TTM)
Gross Margin QoQ = 31.07% (prev 31.48%)
Tobins Q-Ratio = 2.79 (Enterprise Value 47.5b / Total Assets 17.1b)
Interest Expense / Debt = 5.38% (Interest Expense 47.8m / Debt 889.6m)
Taxrate = 26.88% (1.22b / 4.52b)
NOPAT = 3.29b (EBIT 4.50b * (1 - 26.88%))
Current Ratio = 1.96 (Total Current Assets 11.0b / Total Current Liabilities 5.59b)
Debt / Equity = 0.09 (Debt 889.6m / totalStockholderEquity, last quarter 10.3b)
Debt / EBITDA = -0.61 (Net Debt -3.09b / EBITDA 5.06b)
Debt / FCF = -0.84 (Net Debt -3.09b / FCF TTM 3.67b)
Total Stockholder Equity = 9.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.81% (Net Income 3.30b / Total Assets 17.1b)
RoE = 33.90% (Net Income TTM 3.30b / Total Stockholder Equity 9.75b)
RoCE = 43.85% (EBIT 4.50b / Capital Employed (Equity 9.75b + L.T.Debt 515.7m))
RoIC = 30.40% (NOPAT 3.29b / Invested Capital 10.8b)
WACC = 7.21% (E(50.6b)/V(51.5b) * Re(7.27%) + D(889.6m)/V(51.5b) * Rd(5.38%) * (1-Tc(0.27)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.33 | Cagr: -1.01%
[DCF] Terminal Value 73.59% ; FCFF base≈3.87b ; Y1≈3.49b ; Y5≈2.97b
[DCF] Fair Price = 12.46 (EV 47.4b - Net Debt -3.09b = Equity 50.5b / Shares 4.05b; r=8.35% [WACC [floored]]; 5y FCF grow -12.22% → 2.50% )
EPS Correlation: 88.11 | EPS CAGR: 4.84% | SUE: -1.09 | # QB: -2
Revenue Correlation: 99.35 | Revenue CAGR: 3.90% | SUE: -0.76 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.20 | Chg30d=-0.15% | Revisions=-29% | Analysts=7
EPS current Year (2027-03-31): EPS=0.80 | Chg30d=-0.31% | Revisions=-22% | GrowthEPS=-3.6% | GrowthRev=+9.2%
EPS next Year (2028-03-31): EPS=0.84 | Chg30d=-0.65% | Revisions=-10% | GrowthEPS=+5.3% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: -25% (up=6, down=11)